Molulife 200 Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021. Molulife 200 Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molulife 200 Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molulife 200 Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molulife 200 Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Written by: Shubham Kumar Singh, B pharmacy
Reviewed by: Dr. Jay Faldu, MBBS
Last updated on: 24-06-2025
WHO GMP Certified
Long Expiry (>8 Months)
15 Days Easy Returns
Genuine Medicine
Pay On Delivery
Secure Payment
LegitScript Certified Online Pharmacy
Molulife 200 Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021. Molulife 200 Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use. Molulife 200 Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them. Before taking Molulife 200 Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molulife 200 Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Treatment of Mild to moderate Coronavirus disease (COVID-19)
In Treatment of Mild to moderate Coronavirus disease (COVID-19)Molulife 200 Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration. This medicine may help you recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them. ['Headache, Dizziness, Diarrhea']
Follow your doctor's guidance regarding the dose and duration of this medication. Molulife 200 Capsule can be taken it with or without food, although it's advisable to take it consistently at the same time.
Molulife 200 Capsule is an antiviral medicine. It works by inhibiting the SARS-Co V-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.
Alcohol
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Molulife 200 Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Pregnancy
Seek medical advice from your doctor: Molulife 200 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Breast feeding
Not Safe: Molulife 200 Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
Seek medical advice from your doctor: It is not known whether Molulife 200 Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
Safe when prescribed by an expert: Molulife 200 Capsule is safe to use in patients with kidney disease. No dose adjustment of Molulife 200 Capsule is recommended.
Liver
Safe when prescribed by an expert: Molulife 200 Capsule is safe to use in patients with liver disease. No dose adjustment of Molulife 200 Capsule is recommended.
If a dose of Molulife 200 Capsule is missed, it's advisable to consult your doctor.
Do not give Molulife 200 Capsule to children and adolescents aged less than 18 years. Do not stop taking Molulife 200 Capsule without talking to your doctor first, as it will protect you from becoming severely ill from COVID-19. Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing. For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.
208, Okhla Industrial Estate, Phase III, New Delhi - 110020
PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.

More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices